Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cerulean Pharma Inc.
DescriptionNanoparticle conjugated to docetaxel
Molecular Target Tubulin
Mechanism of ActionTubulin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today